Personalized cancer vaccine
個人化癌症疫苗Designed from the unique mutations of each patient’s tumor, to present these targets to the immune system.
Relife develops customized biomedical solutions based on cancer vaccine and NK cell science, guided by patient-derived organoids and AI, and provided only through registered doctors.
精準細胞 × AI驅動 × 更健康的未來
We imagine a future where medicine is designed from each person’s own cells, and where AI turns those signals into insight in days, not years.
Read our visionOur platform brings these technologies together, with the patient’s own cells at the center.
Designed from the unique mutations of each patient’s tumor, to present these targets to the immune system.
Natural killer cells are part of the innate immune system, which can recognize abnormal cells.
Miniature tumors grown from the patient’s own sample, used to compare options in the laboratory first.
AI helps analyze genomic, imaging and laboratory data. Every result is reviewed by scientists and doctors.
We work with the patient’s treating doctor at every step. Medical decisions are always made by the doctor, together with the patient.
The treating doctor refers the patient, with the patient’s consent, and shares the relevant clinical information.
With consent, a tumor and blood sample is analyzed genomically and grown as organoids.
AI-assisted analysis, reviewed by our scientists, is summarized in a report for the doctor.
The treating doctor decides whether and how to proceed. Any treatment is given by a registered doctor under applicable Hong Kong regulations.
From a small sample, we grow patient-derived organoids that keep key features of the original tumor.
Laboratory results from these organoids can give the treating doctor additional information. Organoid results alone do not predict how a treatment will work in the body.
Patients and families can contact us directly or through their doctor. Hospitals and clinics can partner with us.
Contact us to learn about our work. Please speak with your own doctor about any treatment.
Contact usRefer a patient and receive the profiling and organoid results to inform your treatment plan.
Refer a patientPartner with Relife to bring personalized cell-based solutions to your patients.
Become a partnerDoctors can refer a patient, and hospitals, laboratories and investors can explore a partnership. Patients are welcome to contact us; any medical decision is made with your own doctor.